UnitedHealth Group (UNH) Set to Release Quarterly Earnings on Tuesday

Posted by George Bondi on Oct 11th, 2026

UnitedHealth Group (NYSE:UNH – Get Free Report) will likely be announcing its Q3 2026 results before the market opens on Tuesday, October 13th. Analysts expect the company to post earnings of $4.15 per share and revenue of $111.31 billion for the quarter. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Interested persons can find conference call details on the company’s upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Tuesday, October 13, 2026 at 8:00 AM ET.

UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, beating analysts’ consensus estimates of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%. The firm had revenue of $112.03 billion for the quarter, compared to analysts’ expectations of $110.81 billion. During the same period last year, the firm earned $4.08 EPS. The company’s quarterly revenue was up .4% on a year-over-year basis. On average, analysts expect UnitedHealth Group to post $19.85 EPS for the current fiscal year and $22.54 EPS for the next fiscal year.

UnitedHealth Group Stock Up 2.1%

Shares of UNH opened at $378.82 on Friday. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The firm has a market cap of $340.03 billion, a P/E ratio of 24.38, a PEG ratio of 1.43 and a beta of 0.60. The stock’s 50 day moving average is $388.78 and its two-hundred day moving average is $380.29. UnitedHealth Group has a 12 month low of $255.96 and a 12 month high of $461.62.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were given a dividend of $2.32 per share. The ex-dividend date was Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a yield of 2.4%. UnitedHealth Group’s dividend payout ratio is currently 59.72%.

Analysts Set New Price Targets

Several analysts have recently issued reports on UNH shares. DA Davidson set a $512.00 target price on shares of UnitedHealth Group in a research report on Tuesday, July 21st. BMO Capital Markets set a $512.00 price objective on UnitedHealth Group in a report on Tuesday, July 21st. Weiss Ratings upgraded UnitedHealth Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday. Mizuho increased their price objective on UnitedHealth Group from $470.00 to $493.00 and gave the company an “outperform” rating in a research note on Monday, July 20th. Finally, Jefferies Financial Group upped their target price on shares of UnitedHealth Group from $401.00 to $490.00 and gave the stock a “buy” rating in a report on Friday, July 17th. Twenty research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $462.59.

Check Out Our Latest Stock Report on UnitedHealth Group

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

Positive Sentiment: Analysts view UnitedHealth’s diversified healthcare platform, improving Medicare Advantage profitability and lower valuation as advantages over Humana. The stock’s reduced earnings multiple could provide room for a re-rating if the turnaround continues. UnitedHealth vs. Humana: Which Healthcare Giant Has the Edge?
Positive Sentiment: UnitedHealth’s third-quarter earnings are expected to rise sharply year over year, with consensus estimates near $4.12–$4.15 per share on approximately $111.4 billion in revenue. Investors are watching for cost controls, restructuring benefits and a possible increase in 2026 guidance. UnitedHealth Gears Up for Q3 Earnings
Positive Sentiment: One investment thesis argues that UnitedHealth’s deliberate exit from unprofitable businesses is driving meaningful margin expansion despite flat revenue and lower membership. At roughly 16 times projected 2027 earnings, the shares trade below their historical average, leaving potential upside if margin gains prove durable. UnitedHealth: A Beat Is Priced In, But There’s Room For Surprise
Neutral Sentiment: Medicare Advantage star-rating changes are reshuffling the competitive landscape. Humana benefited substantially from improved ratings, while UnitedHealth was described as holding steady; the revised methodology may affect reimbursement and enrollment trends without necessarily reflecting changes in care quality. Humana Soars on Improved Medicare Advantage Star Ratings
Negative Sentiment: TD Cowen lowered its price target for UnitedHealth to $402, reflecting continued caution around margin repair, medical costs and subdued revenue growth. The upcoming earnings report remains an important test of management’s recovery plan. UnitedHealth Group Price Target Lowered

Insiders Place Their Bets

In other news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. This represents a 7.09% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 0.19% of the stock is owned by insiders.

About UnitedHealth Group

(Get Free Report)

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.